Monthly information related to total number of voting rights and shares composing the share capital _October 30, 2022

Rhea-AI Summary

The monthly report dated October 30, 2022, discloses key shareholder information for Erytech Pharma, listed under symbol ERYP on Euronext Paris and Nasdaq. Total shares of the company stand at 31,018,553, with 32,507,991 gross voting rights and 32,505,491 net voting rights. The report complies with Article 223-16 of the French financial regulatory authority, providing crucial data for investors. This report highlights the company's share structure and voting rights, essential for assessing governance and shareholder influence.

Positive

• Total shares composing the share capital remain stable at 31,018,553.
• Gross voting rights increased to 32,507,991, reflecting a positive shareholder base.

Negative

• No significant increase in shares could indicate stagnation in shareholder engagement.

               

Monthly information related to total number of voting rights and shares composing the share capital _October 30, 2022.

Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon – France

---

Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com

Date	Total of shares composing the share capital	Total of brut (1) voting rights	Total of net (2) voting rights
December 31, 2021	31 018 553	32 518 339	32 515 839
January 31, 2022	31 018 553	32 518 339	32 515 839
February 28, 2022	31 018 553	32 518 547	32 516 047
March 31, 2022	31 018 553	32 518 547	32 516 047
April 30, 2022	31 018 553	32 518 547	32 516 047
May 31, 2022	31 018 553	32 518 547	32 516 047
June 30, 2022	31 018 553	32 520 107	32 517 607
July 31, 2022	31 018 553	32 521 126	32 518 626
August 31, 2022	31 018 553	32 508 024	32 505 524
September 30, 2022	31 018 553	32 507 992	32 505 492
October 30, 2022	31 018 553	32 507 991	32 505 491

⁽¹⁾   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
⁽²⁾   Without treasury shares.

Attachment

• CP_Déclaration Droits de Vote 30 10 2022 vENG

FAQ

What are the total shares for Erytech Pharma on October 30, 2022?

As of October 30, 2022, Erytech Pharma has a total of 31,018,553 shares.

What are the gross voting rights for ERYP on October 30, 2022?

The gross voting rights for Erytech Pharma (ERYP) on October 30, 2022, are 32,507,991.

What are the net voting rights for Erytech Pharma as of October 30, 2022?

The net voting rights for Erytech Pharma on October 30, 2022, stand at 32,505,491.

When was the monthly report for Erytech Pharma released?

The monthly report for Erytech Pharma was released on October 30, 2022.

What regulations does the Erytech Pharma report comply with?

The report complies with Article 223-16 of the French Autorité des Marchés Financiers.